{"id":"https://openalex.org/W3006777525","doi":"https://doi.org/10.25026/mpc.v8i1.316","title":"Cost Minimization Analysis (CMA) Antibiotika Pasien Infeksi Saluran Kemih (ISK) Di RSUD Kota Samarinda","display_name":"Cost Minimization Analysis (CMA) Antibiotika Pasien Infeksi Saluran Kemih (ISK) Di RSUD Kota Samarinda","alternate_titles":[],"publication_year":2018,"publication_date":"2018-12-31","ids":{"openalex":"https://openalex.org/W3006777525","doi":"https://doi.org/10.25026/mpc.v8i1.316","mag":"3006777525"},"language":"id","primary_location":{"id":"doi:10.25026/mpc.v8i1.316","doi":"https://doi.org/10.25026/mpc.v8i1.316","is_oa":true,"landing_page_url":"https://doi.org/10.25026/mpc.v8i1.316","pdf_url":null,"source":{"id":"https://openalex.org/S4306523297","display_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","issn_l":"2614-4778","issn":["2614-4778"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315167","host_organization_name":"Mulawarman University","host_organization_lineage":["https://openalex.org/P4310315167"],"host_organization_lineage_names":["Mulawarman University"],"type":"conference"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3006777525"],"child_works_count":0,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25026/mpc.v8i1.316","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030758618","display_name":"Siti Sulaeha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47689905","display_name":"Mulawarman University","ror":"https://ror.org/02kwq2y85","country_code":"ID","type":"education","lineage":["https://openalex.org/I47689905"]}],"countries":["ID"],"is_corresponding":true,"raw_author_name":"Siti Sulaeha","raw_affiliation_strings":["Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\","],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","institution_ids":["https://openalex.org/I47689905"]},{"raw_affiliation_string":"Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\",","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046018121","display_name":"Mirhansyah Ardana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47689905","display_name":"Mulawarman University","ror":"https://ror.org/02kwq2y85","country_code":"ID","type":"education","lineage":["https://openalex.org/I47689905"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Mirhansyah Ardana","raw_affiliation_strings":["Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\","],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","institution_ids":["https://openalex.org/I47689905"]},{"raw_affiliation_string":"Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\",","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067848639","display_name":"Nurul Annisa","orcid":"https://orcid.org/0000-0002-1425-8657","observed_orcids":["https://orcid.org/0000-0002-1425-8657"]},"institutions":[{"id":"https://openalex.org/I47689905","display_name":"Mulawarman University","ror":"https://ror.org/02kwq2y85","country_code":"ID","type":"education","lineage":["https://openalex.org/I47689905"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Nurul Annisa","raw_affiliation_strings":["Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\","],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia","institution_ids":["https://openalex.org/I47689905"]},{"raw_affiliation_string":"Laboratorium Penelitian dan Pengembangan Kefarmasian \"Farmaka Tropis\",","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030758618"],"corresponding_institution_ids":["https://openalex.org/I47689905"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"8","issue":null,"first_page":"143","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8300999999046326,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8300999999046326,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.07039999961853027,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.06800000369548798,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.968999981880188},{"id":"https://openalex.org/keywords/antibiotic-costs","display_name":"antibiotic costs","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cost-minimization-analysis","display_name":"cost-minimization analysis","score":0.8539999723434448},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.7139999866485596},{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.875},{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.6790000200271606},{"id":"https://openalex.org/keywords/samarinda","display_name":"Samarinda","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5283083915710449},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4497515857219696}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25026/mpc.v8i1.316","doi":"https://doi.org/10.25026/mpc.v8i1.316","is_oa":true,"landing_page_url":"https://doi.org/10.25026/mpc.v8i1.316","pdf_url":null,"source":{"id":"https://openalex.org/S4306523297","display_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","issn_l":"2614-4778","issn":["2614-4778"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315167","host_organization_name":"Mulawarman University","host_organization_lineage":["https://openalex.org/P4310315167"],"host_organization_lineage_names":["Mulawarman University"],"type":"conference"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25026/mpc.v8i1.316","doi":"https://doi.org/10.25026/mpc.v8i1.316","is_oa":true,"landing_page_url":"https://doi.org/10.25026/mpc.v8i1.316","pdf_url":null,"source":{"id":"https://openalex.org/S4306523297","display_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","issn_l":"2614-4778","issn":["2614-4778"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315167","host_organization_name":"Mulawarman University","host_organization_lineage":["https://openalex.org/P4310315167"],"host_organization_lineage_names":["Mulawarman University"],"type":"conference"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceeding of Mulawarman Pharmaceuticals Conferences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7087705908","https://openalex.org/W4410735339","https://openalex.org/W3089188610","https://openalex.org/W2992673712","https://openalex.org/W2808147339","https://openalex.org/W3004532782","https://openalex.org/W7221296386","https://openalex.org/W2996685397","https://openalex.org/W3124409696","https://openalex.org/W2800181258"],"abstract_inverted_index":{"Infeksi":[0],"Saluran":[1],"Kemih":[2],"(ISK)":[3],"merupakan":[4,71],"suatu":[5],"istilah":[6],"yang":[7,14,25,30,37,53,103,131],"menggambarkan":[8],"adanya":[9],"infeksi":[10],"melibatkan":[11],"saluran":[12],"kemih":[13],"umumnya":[15],"disebabkan":[16],"oleh":[17],"bakteri":[18],"Escherichia":[19],"coli.":[20],"Penggunaan":[21],"antibiotika":[22,58,100,144],"pada":[23],"pasien":[24,84,101,116],"berbeda":[26,31],"dapat":[27],"memberikan":[28],"biaya":[29,36,52,114,130],"beda":[32],"juga,":[33],"dimana":[34],"dengan":[35,63,117,145],"telah":[38],"dikeluarkan":[39,54,132],"tersebut":[40,127],"belum":[41],"tentu":[42],"menjamin":[43],"efektivitas":[44,56],"kesembuhan":[45],"pasien.":[46],"Penelitian":[47,69],"ini":[48,70],"bertujuan":[49],"untuk":[50,140],"menganalisis":[51],"dan":[55,76,109,121],"penggunaan":[57],"ISK":[59,85,102],"menggunakan":[60,80],"analisis":[61,111],"Farmakoekonomi":[62],"metode":[64,146],"Cost":[65,147],"Minimization":[66],"Analysis":[67,149],"(CMA).":[68],"penelitian":[72,97],"deskriptif":[73],"non":[74],"eksperimental":[75],"dilakukan":[77],"secara":[78],"retrospektif":[79],"data":[81],"rekam":[82],"medik":[83],"di":[86],"RSUD":[87],"Kota":[88],"Samarinda":[89],"periode":[90],"Januari":[91],"2017":[92],"-":[93],"Juni":[94],"2018.":[95],"Hasil":[96],"menunjukan":[98,128],"bahwa":[99,113,129],"paling":[104],"banyak":[105],"digunakan":[106],"adalah":[107],"seftriakson":[108,118],"siprofloksasin,":[110],"menunjukkan":[112],"perawatan":[115],"sebesar":[119,123],"Rp.3.600.138,-":[120],"siprofloksasin":[122],"Rp.3.635.140,-.":[124],"Dari":[125],"hasil":[126],"cenderung":[133],"sama,":[134],"maka":[135],"dibutuhkan":[136],"evaluasi":[137],"ekonomi":[138],"lain":[139],"menilai":[141],"ke":[142],"efektivan":[143],"Effective":[148],"(CEA).":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3006777525","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-03-06T00:00:00"}
